SCHEMBL13665200

SCHEMBL13665200

COc1ccc(NC(=O)c2oc3ccccc3c2N)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 14/20 0.70
▸ ALDH1A1 P00352 6/20 0.70
▸ KDM4E B2RXH2 6/20 0.70
▸ HPGD P15428 4/20 0.70
▸ NPC1 O15118 4/20 0.70
▸ RAB9A P51151 4/20 0.70
▸ HTT P42858 2/20 0.70
▸ USP2 O75604 2/20 0.70
▸ NFKB1 P19838 1/20 0.70
▸ NFKB2 Q00653 1/20 0.70
▸ RELA Q04206 1/20 0.70
▸ SMN1; SMN2 Q16637 5/20 0.67
▸ MEN1 O00255 4/20 0.67
▸ KMT2A Q03164 4/20 0.67
▸ TDP1 Q9NUW8 1/20 0.67
▸ TSHR P16473 5/20 0.66
▸ NPSR1 Q6W5P4 2/20 0.66
▸ MAPK1 P28482 1/20 0.66
▸ TP53 P04637 6/20 0.64
▸ HSD17B10 Q99714 3/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13665178 0.85 MAPT (0.76) MAPTALDH1A1KDM4EHPGDNPC1
SCHEMBL13743910 0.85 NPC1 (0.79) MAPTALDH1A1KDM4EHPGDNPC1
SCHEMBL13665176 0.83 MAPT (0.76) MAPTALDH1A1KDM4EHPGDNPC1
SCHEMBL13665173 0.83 MAPT (1.00) MAPTALDH1A1KDM4EHPGDNPC1
SCHEMBL13515767 0.83 MAPT (0.76) MAPTALDH1A1KDM4EHPGDNPC1
SCHEMBL8805009 0.80 MAPT (1.00) MAPTALDH1A1KDM4EHPGDNPC1
SCHEMBL12501713 0.79 KMT2A (0.78) MAPTALDH1A1KDM4ENPC1RAB9A
SCHEMBL20473331 0.78 MAPT (1.00) MAPTALDH1A1KDM4EHPGDHTT
SCHEMBL1885241 0.76 KDM4E (1.00) MAPTALDH1A1KDM4EHPGDNPC1
SCHEMBL29110126 0.76 MAOB (0.60) MAPTALDH1A1KDM4EHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605158-B2 Carbamoyl-type benzofuran derivatives MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-10-20 — — US disclosed
US-7605158-B2 Carbamoyl-type benzofuran derivatives MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-10-20 — — US disclosed
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 — — US disclosed
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209511-A1 Benzofuran Derivatives F12, F2, F3 MAPT 4681/4885ALDH1A1 693/4885KDM4E 1464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback